1700 OWENS STREET, SUITE 205, SAN FRANCISCO, CA
Market cap: $1.4B (2/10/2026)
Price: $16.11
Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
Investor Presentation
Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors
Announces $250.0 Million Registered Offering of Common Stock
Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus